25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Abeona Therapeutics Inc
Buy, Hold or Sell?

Let's analyze Abeona Therapeutics Inc together

I guess you are interested in Abeona Therapeutics Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Abeona Therapeutics Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Abeona Therapeutics Inc

I send you an email if I find something interesting about Abeona Therapeutics Inc.

1. Quick Overview

1.1. Quick analysis of Abeona Therapeutics Inc (30 sec.)










1.2. What can you expect buying and holding a share of Abeona Therapeutics Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
2.5%

What is your share worth?

Current worth
$0.95
Expected worth in 1 year
$1.40
How sure are you?
27.5%

+ What do you gain per year?

Total Gains per Share
$0.45
Return On Investment
7.6%

For what price can you sell your share?

Current Price per Share
$5.89
Expected price per share
$5.32 - $6.78
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Abeona Therapeutics Inc (5 min.)




Live pricePrice per Share (EOD)
$5.89
Intrinsic Value Per Share
$-12.51 - $-8.90
Total Value Per Share
$-11.56 - $-7.95

2.2. Growth of Abeona Therapeutics Inc (5 min.)




Is Abeona Therapeutics Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$45.7m$19.2m$12m38.5%

How much money is Abeona Therapeutics Inc making?

Current yearPrevious yearGrowGrow %
Making money-$17.7m-$7.7m-$9.9m-56.1%
Net Profit Margin-146.9%2,239.5%--

How much money comes from the company's main activities?

2.3. Financial Health of Abeona Therapeutics Inc (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#459 / 944

Most Revenue
#529 / 944

Most Profit
#650 / 944

Most Efficient
#489 / 944
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Abeona Therapeutics Inc?

Welcome investor! Abeona Therapeutics Inc's management wants to use your money to grow the business. In return you get a share of Abeona Therapeutics Inc.

First you should know what it really means to hold a share of Abeona Therapeutics Inc. And how you can make/lose money.

Speculation

The Price per Share of Abeona Therapeutics Inc is $5.89. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Abeona Therapeutics Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Abeona Therapeutics Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.95. Based on the TTM, the Book Value Change Per Share is $0.11 per quarter. Based on the YOY, the Book Value Change Per Share is $0.04 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Abeona Therapeutics Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.63-10.7%-0.40-6.8%-0.31-5.3%-0.40-6.9%-0.31-5.3%
Usd Book Value Change Per Share-0.48-8.1%0.111.9%0.040.6%-0.06-1.1%0.040.7%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%6.66113.1%
Usd Total Gains Per Share-0.48-8.1%0.111.9%0.040.6%-0.06-1.1%6.70113.8%
Usd Price Per Share6.32-5.71-3.54-2.81-5.00-
Price to Earnings Ratio-2.51--0.24--2.97--1.43--6.33-
Price-to-Total Gains Ratio-13.23--13.53--1.93--7.21--6.24-
Price to Book Ratio6.64--2.80-9.65-2.15-4.31-
Price-to-Total Gains Ratio-13.23--13.53--1.93--7.21--6.24-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share5.89
Number of shares169
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.11-0.06
Usd Total Gains Per Share0.11-0.06
Gains per Quarter (169 shares)18.80-10.63
Gains per Year (169 shares)75.21-42.51
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
1075650-43-53
201501400-85-96
302262150-128-139
403012900-170-182
503763650-213-225
604514400-255-268
705265150-298-311
806025900-340-354
906776650-383-397
1007527400-425-440

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share1.03.00.025.0%1.011.00.08.3%1.019.00.05.0%1.039.00.02.5%11.0105.00.09.5%
Book Value Change Per Share1.03.00.025.0%3.09.00.025.0%4.016.00.020.0%11.029.00.027.5%31.080.05.026.7%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.020.00.0%1.00.039.02.5%17.00.099.014.7%
Total Gains per Share1.03.00.025.0%3.09.00.025.0%4.016.00.020.0%11.029.00.027.5%37.074.05.031.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Abeona Therapeutics Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.4780.111-529%0.038-1354%-0.063-87%0.041-1258%
Book Value Per Share--0.9520.630+51%0.442+115%1.395-32%1.778-46%
Current Ratio--6.1155.839+5%6.022+2%3.970+54%8.026-24%
Debt To Asset Ratio--0.6200.740-16%0.681-9%0.497+25%0.353+76%
Debt To Equity Ratio--1.6351.445+13%2.494-34%1.157+41%0.806+103%
Dividend Per Share----0%-0%-0%6.659-100%
Enterprise Value--338758710.560283136360.540+20%159351735.000+113%152242408.358+123%254739759.679+33%
Eps---0.630-0.398-37%-0.312-50%-0.404-36%-0.313-50%
Ev To Ebitda Ratio---2.977-0.514-83%-3.684+24%-2.324-22%-9.765+228%
Ev To Sales Ratio--infinfnan%infnan%infnan%infnan%
Free Cash Flow Per Share---0.263-0.272+4%-0.242-8%-0.277+5%-0.232-12%
Free Cash Flow To Equity Per Share---0.2690.275-198%0.174-255%0.164-264%20.590-101%
Gross Profit Margin--1.0001.017-2%1.051-5%1.013-1%1.007-1%
Intrinsic Value_10Y_max---8.902--------
Intrinsic Value_10Y_min---12.512--------
Intrinsic Value_1Y_max---0.925--------
Intrinsic Value_1Y_min---1.201--------
Intrinsic Value_3Y_max---2.754--------
Intrinsic Value_3Y_min---3.675--------
Intrinsic Value_5Y_max---4.552--------
Intrinsic Value_5Y_min---6.205--------
Market Cap256044190.000-19%303876710.560263508110.540+15%153669985.000+98%125461208.358+142%219030584.679+39%
Net Profit Margin----1.4690%22.395-100%-0.5640%-8.8110%
Operating Margin----1.4590%-42.6720%-12.1500%-13.3750%
Operating Ratio---1.169-100%45.396-100%13.296-100%22.138-100%
Pb Ratio6.187-7%6.639-2.798+142%9.649-31%2.151+209%4.315+54%
Pe Ratio-2.339+7%-2.510-0.239-90%-2.968+18%-1.427-43%-6.330+152%
Price Per Share5.890-7%6.3205.705+11%3.535+79%2.815+125%5.003+26%
Price To Free Cash Flow Ratio-5.602+7%-6.011-5.275-12%-4.274-29%-3.319-45%-8.915+48%
Price To Total Gains Ratio-12.328+7%-13.228-13.532+2%-1.928-85%-7.214-45%-6.243-53%
Quick Ratio--11.1449.963+12%10.542+6%6.389+74%9.793+14%
Return On Assets---0.251-0.219-13%-0.140-44%-0.184-27%-0.148-41%
Return On Equity---0.661-0.420-37%-0.641-3%-0.401-39%-0.321-52%
Total Gains Per Share---0.4780.111-529%0.038-1354%-0.063-87%6.700-107%
Usd Book Value--45773000.00031239750.000+47%19221000.000+138%61395150.000-25%77662875.000-41%
Usd Book Value Change Per Share---0.4780.111-529%0.038-1354%-0.063-87%0.041-1258%
Usd Book Value Per Share--0.9520.630+51%0.442+115%1.395-32%1.778-46%
Usd Dividend Per Share----0%-0%-0%6.659-100%
Usd Enterprise Value--338758710.560283136360.540+20%159351735.000+113%152242408.358+123%254739759.679+33%
Usd Eps---0.630-0.398-37%-0.312-50%-0.404-36%-0.313-50%
Usd Free Cash Flow---12638000.000-12642000.000+0%-10521250.000-17%-12213750.000-3%-10175025.000-19%
Usd Free Cash Flow Per Share---0.263-0.272+4%-0.242-8%-0.277+5%-0.232-12%
Usd Free Cash Flow To Equity Per Share---0.2690.275-198%0.174-255%0.164-264%20.590-101%
Usd Market Cap256044190.000-19%303876710.560263508110.540+15%153669985.000+98%125461208.358+142%219030584.679+39%
Usd Price Per Share5.890-7%6.3205.705+11%3.535+79%2.815+125%5.003+26%
Usd Profit---30269000.000-17758000.000-41%-7795500.000-74%-16275800.000-46%-12942475.000-57%
Usd Revenue---706000.000-100%892000.000-100%1186900.000-100%690200.000-100%
Usd Total Gains Per Share---0.4780.111-529%0.038-1354%-0.063-87%6.700-107%
 EOD+3 -5MRQTTM+18 -17YOY+16 -205Y+12 -2310Y+8 -29

3.3 Fundamental Score

Let's check the fundamental score of Abeona Therapeutics Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.339
Price to Book Ratio (EOD)Between0-16.187
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than111.144
Current Ratio (MRQ)Greater than16.115
Debt to Asset Ratio (MRQ)Less than10.620
Debt to Equity Ratio (MRQ)Less than11.635
Return on Equity (MRQ)Greater than0.15-0.661
Return on Assets (MRQ)Greater than0.05-0.251
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Abeona Therapeutics Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5042.613
Ma 20Greater thanMa 506.006
Ma 50Greater thanMa 1006.242
Ma 100Greater thanMa 2005.811
OpenGreater thanClose5.900
Total3/5 (60.0%)

4. In-depth Analysis

4.1 About Abeona Therapeutics Inc

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases. Its lead clinical program is EB-101, an autologous, engineered cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company develops ABO-503 for the treatment of X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 for the treatment of autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. is headquartered in Cleveland, Ohio.

Fundamental data was last updated by Penke on 2024-12-03 21:18:02.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Abeona Therapeutics Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Abeona Therapeutics Inc to the Biotechnology industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Abeona Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-146.9%+146.9%
TTM-146.9%YOY2,239.5%-2,386.4%
TTM-146.9%5Y-56.4%-90.4%
5Y-56.4%10Y-881.1%+824.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--108.6%+108.6%
TTM-146.9%-221.4%+74.5%
YOY2,239.5%-207.4%+2,446.9%
5Y-56.4%-346.2%+289.8%
10Y-881.1%-470.4%-410.7%
4.3.1.2. Return on Assets

Shows how efficient Abeona Therapeutics Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Abeona Therapeutics Inc to the Biotechnology industry mean.
  • -25.1% Return on Assets means that Abeona Therapeutics Inc generated $-0.25 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Abeona Therapeutics Inc:

  • The MRQ is -25.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -21.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.1%TTM-21.9%-3.2%
TTM-21.9%YOY-14.0%-7.9%
TTM-21.9%5Y-18.4%-3.5%
5Y-18.4%10Y-14.8%-3.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.1%-11.6%-13.5%
TTM-21.9%-12.0%-9.9%
YOY-14.0%-11.2%-2.8%
5Y-18.4%-12.6%-5.8%
10Y-14.8%-14.1%-0.7%
4.3.1.3. Return on Equity

Shows how efficient Abeona Therapeutics Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Abeona Therapeutics Inc to the Biotechnology industry mean.
  • -66.1% Return on Equity means Abeona Therapeutics Inc generated $-0.66 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Abeona Therapeutics Inc:

  • The MRQ is -66.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -42.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-66.1%TTM-42.0%-24.1%
TTM-42.0%YOY-64.1%+22.2%
TTM-42.0%5Y-40.1%-1.9%
5Y-40.1%10Y-32.1%-8.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-66.1%-14.5%-51.6%
TTM-42.0%-16.0%-26.0%
YOY-64.1%-14.6%-49.5%
5Y-40.1%-18.5%-21.6%
10Y-32.1%-19.2%-12.9%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Abeona Therapeutics Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Abeona Therapeutics Inc is operating .

  • Measures how much profit Abeona Therapeutics Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Abeona Therapeutics Inc to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Abeona Therapeutics Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-145.9%+145.9%
TTM-145.9%YOY-4,267.2%+4,121.3%
TTM-145.9%5Y-1,215.0%+1,069.1%
5Y-1,215.0%10Y-1,337.5%+122.5%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--204.0%+204.0%
TTM-145.9%-316.8%+170.9%
YOY-4,267.2%-215.6%-4,051.6%
5Y-1,215.0%-376.1%-838.9%
10Y-1,337.5%-480.3%-857.2%
4.3.2.2. Operating Ratio

Measures how efficient Abeona Therapeutics Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are $0.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Abeona Therapeutics Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM1.169-1.169
TTM1.169YOY45.396-44.227
TTM1.1695Y13.296-12.127
5Y13.29610Y22.138-8.841
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.284-2.284
TTM1.1693.198-2.029
YOY45.3963.247+42.149
5Y13.2964.651+8.645
10Y22.1386.419+15.719
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Abeona Therapeutics Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Abeona Therapeutics Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 6.12 means the company has $6.12 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Abeona Therapeutics Inc:

  • The MRQ is 6.115. The company is very able to pay all its short-term debts. +2
  • The TTM is 5.839. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.115TTM5.839+0.276
TTM5.839YOY6.022-0.183
TTM5.8395Y3.970+1.869
5Y3.97010Y8.026-4.056
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1153.586+2.529
TTM5.8393.869+1.970
YOY6.0224.644+1.378
5Y3.9705.971-2.001
10Y8.0266.240+1.786
4.4.3.2. Quick Ratio

Measures if Abeona Therapeutics Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Abeona Therapeutics Inc to the Biotechnology industry mean.
  • A Quick Ratio of 11.14 means the company can pay off $11.14 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Abeona Therapeutics Inc:

  • The MRQ is 11.144. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 9.963. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ11.144TTM9.963+1.181
TTM9.963YOY10.542-0.579
TTM9.9635Y6.389+3.574
5Y6.38910Y9.793-3.404
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ11.1443.093+8.051
TTM9.9633.392+6.571
YOY10.5424.304+6.238
5Y6.3895.953+0.436
10Y9.7936.435+3.358
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Abeona Therapeutics Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Abeona Therapeutics Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Abeona Therapeutics Inc to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.62 means that Abeona Therapeutics Inc assets are financed with 62.0% credit (debt) and the remaining percentage (100% - 62.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Abeona Therapeutics Inc:

  • The MRQ is 0.620. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.740. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.620TTM0.740-0.120
TTM0.740YOY0.681+0.059
TTM0.7405Y0.497+0.243
5Y0.49710Y0.353+0.144
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6200.346+0.274
TTM0.7400.347+0.393
YOY0.6810.313+0.368
5Y0.4970.365+0.132
10Y0.3530.383-0.030
4.5.4.2. Debt to Equity Ratio

Measures if Abeona Therapeutics Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Abeona Therapeutics Inc to the Biotechnology industry mean.
  • A Debt to Equity ratio of 163.5% means that company has $1.63 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Abeona Therapeutics Inc:

  • The MRQ is 1.635. The company is just able to pay all its debts with equity.
  • The TTM is 1.445. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.635TTM1.445+0.189
TTM1.445YOY2.494-1.049
TTM1.4455Y1.157+0.288
5Y1.15710Y0.806+0.351
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6350.393+1.242
TTM1.4450.432+1.013
YOY2.4940.388+2.106
5Y1.1570.455+0.702
10Y0.8060.498+0.308
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Abeona Therapeutics Inc generates.

  • Above 15 is considered overpriced but always compare Abeona Therapeutics Inc to the Biotechnology industry mean.
  • A PE ratio of -2.51 means the investor is paying $-2.51 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Abeona Therapeutics Inc:

  • The EOD is -2.339. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.510. Based on the earnings, the company is expensive. -2
  • The TTM is -0.239. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.339MRQ-2.510+0.171
MRQ-2.510TTM-0.239-2.271
TTM-0.239YOY-2.968+2.729
TTM-0.2395Y-1.427+1.188
5Y-1.42710Y-6.330+4.903
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.339-2.180-0.159
MRQ-2.510-2.507-0.003
TTM-0.239-3.153+2.914
YOY-2.968-3.242+0.274
5Y-1.427-5.992+4.565
10Y-6.330-6.690+0.360
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Abeona Therapeutics Inc:

  • The EOD is -5.602. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -6.011. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -5.275. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-5.602MRQ-6.011+0.409
MRQ-6.011TTM-5.275-0.736
TTM-5.275YOY-4.274-1.000
TTM-5.2755Y-3.319-1.956
5Y-3.31910Y-8.915+5.596
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-5.602-2.879-2.723
MRQ-6.011-3.276-2.735
TTM-5.275-3.669-1.606
YOY-4.274-4.485+0.211
5Y-3.319-8.015+4.696
10Y-8.915-9.197+0.282
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Abeona Therapeutics Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 6.64 means the investor is paying $6.64 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Abeona Therapeutics Inc:

  • The EOD is 6.187. Based on the equity, the company is overpriced. -1
  • The MRQ is 6.639. Based on the equity, the company is overpriced. -1
  • The TTM is -2.798. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD6.187MRQ6.639-0.452
MRQ6.639TTM-2.798+9.437
TTM-2.798YOY9.649-12.447
TTM-2.7985Y2.151-4.949
5Y2.15110Y4.315-2.164
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD6.1871.964+4.223
MRQ6.6392.056+4.583
TTM-2.7982.388-5.186
YOY9.6492.460+7.189
5Y2.1513.697-1.546
10Y4.3154.324-0.009
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Abeona Therapeutics Inc.

4.8.1. Institutions holding Abeona Therapeutics Inc

Institutions are holding 77.543% of the shares of Abeona Therapeutics Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-09-30Suvretta Capital Management, LLC8.47810.7453368550300
2024-09-30Nantahala Capital Management, LLC7.89641.09753432637-3507437-50.5389
2024-09-30Adage Capital Partners Gp LLC7.47620.0363324999400
2024-09-30Millennium Management LLC5.29460.00692301628-375023-14.0109
2024-09-30Vanguard Group Inc4.61830.00022007626541252.7707
2024-09-30Vivo Capital, LLC4.2390.9638184275100
2024-09-30Rosalind Advisors, Inc.4.21437.41231832000820004.6857
2024-09-30Western Standard LLC3.906310.069616980971109986.9938
2024-09-30LAURION CAPITAL MANAGEMENT LP3.00570.11211306589-200191-13.286
2024-09-30Walleye Trading Advisors, LLC1.98130.0113861301-129083-13.0336
2024-09-30683 Capital Management LLC1.55280.32446750007500012.5
2024-09-30Propel Bio Management LLC1.43552.2875624022-624022-50
2024-09-30Citigroup Inc1.41860.002361666812633225.7644
2024-09-30Ikarian Capital, LLC1.34250.5143583593-185000-24.07
2024-09-30Geode Capital Management, LLC1.07040.00024653178305021.7257
2024-06-30BlackRock Inc1.0270446439225890102.4217
2024-09-30Simplify Asset Management Inc.0.93990.120340858400
2024-09-30Newtyn Management LLC0.87410.368638000000
2024-09-30abrdn PLC0.75220.0038326995200647158.805
2024-06-30Bank of America Corp0.53140.0001230987207978903.8985
Total 62.054624.076826975731-3854736-14.3%

4.9.2. Funds holding Abeona Therapeutics Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-10-31Vanguard Total Stock Mkt Idx Inv2.83510.0005123246500
2024-10-31Vanguard Institutional Extnd Mkt Idx Tr1.55990.004678098-24964-3.5508
2024-10-31Simplify Propel Opportunities ETF0.93992.545140858400
2024-10-31abrdn Life Sciences Investors0.75220.460532699500
2024-09-30Fidelity Extended Market Index0.55240.0036240132-3547-1.4556
2024-09-30BlackRock Extended Equity Market K0.2210.004196052-41-0.0427
2024-11-27iShares Micro-Cap ETF0.20540.05748929700
2024-09-30Fidelity Total Market Index0.17420.0005757461405622.7849
2024-09-30Fidelity Series Total Market Index0.12760.000555474-1693-2.9615
2024-09-30NT Ext Equity Mkt Idx Fd - NL0.11330.00464924800
2024-09-30Fidelity Nasdaq Composite Index0.10090.00164388300
2024-09-30Northern Trust Extended Eq Market Idx0.09880.00374293100
2024-09-30NT Ext Equity Mkt Idx Fd - L0.09880.00374293100
2024-09-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.09130.0046396791210.3059
2024-09-30Onelife Fund USD0.07270.80663161600
2024-10-31Vanguard Instl Ttl Stk Mkt Idx InstlPls0.07020.00073050500
2024-09-30Vanguard Instl Ttl Stck Mkt Idx Tr0.07020.00063050500
2024-09-30Spartan Extended Market Index Pool E0.05750.003624997-855-3.3073
2024-09-30Spartan Total Market Index Pool E0.05670.000424645-7442-23.1932
2024-10-31Schwab Total Stock Market Index0.05490.00062385000
Total 8.2533.90693587633-24365-0.7%

5.3. Insider Transactions

Insiders are holding 5.104% of the shares of Abeona Therapeutics Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-05-16Leila AllandBUY110004.71
2024-04-26Faith L CharlesBUY75503.28
2024-04-25Brendan M O'malleyBUY86003.24
2024-04-25Joseph Walter VazzanoBUY56083.14
2024-04-25Vishwas SeshadriBUY100003.2
2024-01-17Mark AlvinoSELL70845.11
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2024-09-30. Currency in USD. All numbers in thousands.

Summary
Total Assets120,592
Total Liabilities74,819
Total Stockholder Equity45,773
 As reported
Total Liabilities 74,819
Total Stockholder Equity+ 45,773
Total Assets = 120,592

Assets

Total Assets120,592
Total Current Assets112,657
Long-term Assets7,935
Total Current Assets
Cash And Cash Equivalents 15,726
Short-term Investments 93,975
Net Receivables 1,613
Other Current Assets 1,343
Total Current Assets  (as reported)112,657
Total Current Assets  (calculated)112,657
+/-0
Long-term Assets
Property Plant Equipment 7,847
Long-term Assets Other 88
Long-term Assets  (as reported)7,935
Long-term Assets  (calculated)7,935
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities18,422
Long-term Liabilities56,397
Total Stockholder Equity45,773
Total Current Liabilities
Short-term Debt 6,558
Short Long Term Debt 4,444
Accounts payable 2,789
Other Current Liabilities 9,075
Total Current Liabilities  (as reported)18,422
Total Current Liabilities  (calculated)22,866
+/- 4,444
Long-term Liabilities
Long term Debt 14,206
Capital Lease Obligations 4,459
Long-term Liabilities  (as reported)56,397
Long-term Liabilities  (calculated)18,665
+/- 37,732
Total Stockholder Equity
Common Stock434
Retained Earnings -803,965
Accumulated Other Comprehensive Income -84
Other Stockholders Equity 849,388
Total Stockholder Equity (as reported)45,773
Total Stockholder Equity (calculated)45,773
+/-0
Other
Capital Stock434
Cash and Short Term Investments 109,701
Common Stock Shares Outstanding 48,082
Liabilities and Stockholders Equity 120,592
Net Debt 7,383
Net Invested Capital 64,423
Net Working Capital 94,235
Property Plant and Equipment Gross 22,288
Short Long Term Debt Total 23,109



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-312012-09-302012-06-302012-03-312011-12-312011-09-302011-06-302011-03-312010-12-312010-09-302010-06-302010-03-312009-12-312009-09-302009-06-302009-03-312008-12-312008-09-302008-06-302008-03-312007-12-312007-09-302007-06-302007-03-312006-12-312006-09-302006-06-302006-03-312005-12-312005-09-302005-06-302005-03-312004-12-312004-09-302004-06-302004-03-312003-12-312003-09-302003-06-302003-03-312002-12-312002-09-302002-06-302002-03-312001-12-312001-09-302001-06-302001-03-312000-12-312000-09-302000-06-302000-03-311999-12-311999-09-301999-06-301999-03-311998-12-311998-09-301998-06-301998-03-311997-12-311997-09-301997-06-301997-03-311996-12-311996-09-301996-06-301996-03-311995-12-31
> Total Assets 
400
400
6,400
5,600
4,900
3,900
3,000
2,400
1,400
1,400
3,000
3,000
2,400
1,707
1,135
5,367
4,600
18,229
17,195
31,638
30,526
30,526
27,806
26,453
25,487
25,487
22,882
20,031
19,487
16,743
16,340
13,029
11,811
18,496
15,800
13,663
11,090
11,761
9,228
7,811
7,811
7,213
8,256
7,073
6,426
4,876
3,634
3,500
9,149
7,352
6,920
5,754
4,257
3,624
2,351
2,705
1,583
5,195
3,625
2,279
8,771
6,876
5,065
2,220
3,785
3,196
2,437
1,234
1,730
1,721
2,397
1,092
613
478
240
280
16,582
13,117
76,925
89,549
80,055
77,420
74,152
73,814
111,058
105,284
96,659
95,731
178,766
175,653
166,697
160,576
174,399
166,136
159,410
142,772
223,382
175,003
164,378
159,365
151,198
141,432
130,675
119,019
79,586
55,172
44,719
38,761
64,214
53,345
53,550
66,087
64,002
74,828
134,003
120,592
120,592134,00374,82864,00266,08753,55053,34564,21438,76144,71955,17279,586119,019130,675141,432151,198159,365164,378175,003223,382142,772159,410166,136174,399160,576166,697175,653178,76695,73196,659105,284111,05873,81474,15277,42080,05589,54976,92513,11716,5822802404786131,0922,3971,7211,7301,2342,4373,1963,7852,2205,0656,8768,7712,2793,6255,1951,5832,7052,3513,6244,2575,7546,9207,3529,1493,5003,6344,8766,4267,0738,2567,2137,8117,8119,22811,76111,09013,66315,80018,49611,81113,02916,34016,74319,48720,03122,88225,48725,48726,45327,80630,52630,52631,63817,19518,2294,6005,3671,1351,7072,4003,0003,0001,4001,4002,4003,0003,9004,9005,6006,400400400
   > Total Current Assets 
0
6,900
6,100
5,300
4,600
3,700
2,600
1,600
500
500
2,200
2,200
1,500
944
418
2,060
1,074
14,676
13,729
27,368
26,389
26,389
23,926
22,439
20,930
20,930
16,658
12,653
12,362
9,741
9,348
5,948
4,819
11,680
9,291
6,772
4,270
5,194
2,986
1,924
1,924
5,159
6,339
5,468
5,031
3,796
2,625
2,567
8,297
6,531
6,158
5,058
3,550
2,460
1,302
1,740
685
4,363
2,848
1,565
8,121
6,269
4,472
1,686
3,313
2,769
2,031
851
1,681
1,673
2,349
1,044
575
440
203
244
11,555
8,190
30,962
43,690
40,568
37,840
34,621
31,947
69,421
63,823
59,268
58,395
140,592
134,151
121,826
114,551
88,851
71,721
64,895
49,592
132,390
118,758
108,803
104,560
97,742
88,597
78,880
67,905
55,401
39,204
30,296
25,497
53,099
42,844
44,038
57,264
55,737
66,725
125,904
112,657
112,657125,90466,72555,73757,26444,03842,84453,09925,49730,29639,20455,40167,90578,88088,59797,742104,560108,803118,758132,39049,59264,89571,72188,851114,551121,826134,151140,59258,39559,26863,82369,42131,94734,62137,84040,56843,69030,9628,19011,5552442034405751,0442,3491,6731,6818512,0312,7693,3131,6864,4726,2698,1211,5652,8484,3636851,7401,3022,4603,5505,0586,1586,5318,2972,5672,6253,7965,0315,4686,3395,1591,9241,9242,9865,1944,2706,7729,29111,6804,8195,9489,3489,74112,36212,65316,65820,93020,93022,43923,92626,38926,38927,36813,72914,6761,0742,0604189441,5002,2002,2005005001,6002,6003,7004,6005,3006,1006,9000
       Cash And Cash Equivalents 
0
6,800
6,000
5,200
4,400
3,500
2,500
1,300
400
400
2,200
2,200
1,500
887
258
2,026
869
3,419
999
7,166
8,415
8,415
5,615
8,723
7,426
7,426
5,608
1,845
1,444
3,223
3,290
446
727
8,356
6,148
4,491
1,775
2,888
784
378
378
349
1,429
482
1,194
359
170
661
159
226
96
201
2,663
2,206
1,231
1,672
607
4,278
2,758
1,496
7,033
6,174
4,346
1,348
2,460
1,365
588
106
396
50
1,798
899
424
299
55
165
11,520
7,948
30,410
43,282
40,138
37,395
34,303
31,185
69,142
63,212
58,304
56,522
137,750
131,995
49,990
33,599
18,750
25,924
42,609
47,923
129,258
40,155
14,542
8,424
12,596
14,265
27,179
43,781
32,938
20,326
6,133
5,733
14,217
4,680
6,225
4,712
14,473
17,558
34,426
15,726
15,72634,42617,55814,4734,7126,2254,68014,2175,7336,13320,32632,93843,78127,17914,26512,5968,42414,54240,155129,25847,92342,60925,92418,75033,59949,990131,995137,75056,52258,30463,21269,14231,18534,30337,39540,13843,28230,4107,94811,520165552994248991,798503961065881,3652,4601,3484,3466,1747,0331,4962,7584,2786071,6721,2312,2062,663201962261596611703591,1944821,4293493783787842,8881,7754,4916,1488,3567274463,2903,2231,4441,8455,6087,4267,4268,7235,6158,4158,4157,1669993,4198692,0262588871,5002,2002,2004004001,3002,5003,5004,4005,2006,0006,8000
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,645
8,204
7,864
17,394
17,394
18,174
13,300
12,700
12,700
9,800
9,800
8,332
4,153
4,181
3,915
1,860
939
969
535
486
472
504
92
92
125
188
223
3,195
2,724
1,730
515
6,762
6,163
5,792
4,417
0
0
0
0
0
0
0
0
0
0
0
0
330
330
330
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
69,852
78,625
66,218
42,387
19,903
0
0
75,887
93,337
88,447
82,438
72,506
50,380
23,217
12,086
10,989
13,963
12,434
37,932
35,684
30,547
49,042
37,753
44,786
88,282
93,975
93,97588,28244,78637,75349,04230,54735,68437,93212,43413,96310,98912,08623,21750,38072,50682,43888,44793,33775,8870019,90342,38766,21878,62569,852000000000000000000000003303303300000000000004,4175,7926,1636,7625151,7302,7243,19522318812592925044724865359699391,8603,9154,1814,1538,3329,8009,80012,70012,70013,30018,17417,39417,3947,8648,2046,64500000000000000000
       Net Receivables 
0
0
0
0
0
0
0
100
0
0
0
0
0
12
32
3
88
212
140
440
447
447
69
327
193
193
669
226
1,273
1,497
1,081
642
1,226
1,189
1,128
819
791
764
810
765
765
4,488
4,641
4,709
359
356
208
861
966
966
105
330
782
130
15
23
36
35
38
40
1,018
46
51
119
333
934
788
481
840
1,231
259
56
74
59
58
3
35
144
330
271
115
244
112
606
124
148
97
111
107
64
47
352
81
38
40
15
0
0
0
7,000
0
0
0
0
3,000
0
2,869
1,047
188
519
5,727
2,209
2,444
2,232
1,640
1,613
1,6131,6402,2322,4442,2095,7275191881,0472,86903,00000007,00000015403881352476410711197148124606112244115271330144353585974562591,23184048178893433311951461,0184038353623151307823301059669668612083563594,7094,6414,4887657658107647918191,1281,1891,2266421,0811,4971,273226669193193327694474474401402128833212000001000000000
       Other Current Assets 
0
100
100
100
200
200
100
200
0
100
0
0
0
45
128
31
117
4,315
4,315
11,815
133
133
68
89
611
611
581
782
852
630
591
600
898
1,088
938
774
1,093
957
827
645
645
-1
81
54
283
357
517
530
410
142
165
110
105
124
56
45
42
50
52
29
70
49
75
27
369
373
374
28
251
242
292
89
77
82
90
76
0
98
222
137
315
201
206
156
155
463
867
1,762
2,735
2,092
1,937
1,975
3,802
3,372
2,343
1,654
3,132
2,716
924
689
2,708
1,826
1,321
907
7,377
1,998
1,440
945
424
1,623
1,201
1,301
1,067
2,149
1,556
1,343
1,3431,5562,1491,0671,3011,2011,6234249451,4401,9987,3779071,3211,8262,7086899242,7163,1321,6542,3433,3723,8021,9751,9372,0922,7351,762867463155156206201315137222980769082778929224225128374373369277549702952504245561241051101651424105305173572835481-16456458279571,0937749381,088898600591630852782581611611896813313311,8154,3154,315117311284500010002001002002001001001000
   > Long-term Assets 
0
400
300
300
300
200
400
800
0
900
800
800
900
763
717
3,307
3,526
3,553
3,466
4,270
0
4,137
3,880
4,014
0
4,557
6,224
7,378
7,125
7,002
6,992
7,081
6,992
6,816
6,509
6,891
6,820
6,567
6,242
5,887
5,887
2,054
1,917
1,605
1,395
1,080
1,009
933
852
821
762
696
707
1,164
1,049
965
898
832
777
714
650
607
593
534
472
427
406
383
49
48
48
48
38
38
37
36
5,027
4,927
45,963
45,859
39,487
39,580
39,531
41,867
41,637
41,461
37,391
37,336
38,174
41,502
44,871
46,025
85,548
94,415
94,515
93,180
90,992
56,245
55,575
54,805
53,456
52,835
51,795
51,114
24,185
15,968
14,423
13,264
11,115
10,501
9,512
8,823
8,265
8,103
8,099
7,935
7,9358,0998,1038,2658,8239,51210,50111,11513,26414,42315,96824,18551,11451,79552,83553,45654,80555,57556,24590,99293,18094,51594,41585,54846,02544,87141,50238,17437,33637,39141,46141,63741,86739,53139,58039,48745,85945,9634,9275,02736373838484848493834064274725345936076507147778328989651,0491,1647076967628218529331,0091,0801,3951,6051,9172,0545,8875,8876,2426,5676,8206,8916,5096,8166,9927,0816,9927,0027,1257,3786,2244,55704,0143,8804,13704,2703,4663,5533,5263,30771776390080080090008004002003003003004000
       Property Plant Equipment 
400
400
300
300
300
300
300
300
400
400
300
300
200
192
159
136
108
122
123
107
116
116
128
398
477
477
730
763
742
798
968
941
1,004
1,009
981
1,090
1,040
982
930
864
864
300
258
236
212
207
190
156
130
142
124
100
87
83
70
59
50
42
44
38
32
46
57
55
51
59
53
46
7
6
6
6
6
6
5
4
4
11
66
87
350
548
639
748
721
748
709
730
1,374
4,789
8,007
9,245
9,443
19,105
22,136
22,100
21,204
20,667
20,179
19,390
18,354
17,742
16,729
16,076
21,742
15,948
14,403
13,244
11,072
10,402
9,404
8,684
7,988
7,989
7,999
7,847
7,8477,9997,9897,9888,6849,40410,40211,07213,24414,40315,94821,74216,07616,72917,74218,35419,39020,17920,66721,20422,10022,13619,1059,4439,2458,0074,7891,374730709748721748639548350876611445666667465359515557463238444250597083871001241421301561902072122362583008648649309821,0401,0909811,0091,004941968798742763730477477398128116116107123122108136159192200300300400400300300300300300300400400
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,115
0
0
0
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
1,868
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
38,955
38,955
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
32,466
0
0
0
0
0
0
0
0
0
0
0
0
00000000000032,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46632,46638,95538,955000000000000000000000000000000000000001,8681,8681,8681,8681,8681,8681,8681,8681,8681,8681,8681,8681,8681,8681,8681,8680002,11500000000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
500
500
500
500
400
400
413
400
3,013
3,260
3,273
3,185
3,097
3,002
3,002
2,823
2,733
2,642
2,642
2,586
5,417
3,440
5,203
5,097
3,125
4,887
4,782
4,677
4,572
2,440
4,212
4,114
4,018
4,018
1,121
1,012
958
903
848
794
752
710
667
626
584
542
962
909
840
787
734
681
627
574
521
468
415
362
313
302
291
0
0
0
0
0
0
0
0
4,991
4,875
6,900
6,755
6,609
6,464
6,318
8,587
8,384
8,181
4,150
4,063
3,977
3,890
3,803
3,717
43,042
41,697
38,765
37,471
36,178
1,968
1,924
1,881
1,500
1,471
1,442
1,413
1,384
0
0
0
0
0
0
0
0
0
0
0
000000000001,3841,4131,4421,4711,5001,8811,9241,96836,17837,47138,76541,69743,0423,7173,8033,8903,9774,0634,1508,1818,3848,5876,3186,4646,6096,7556,9004,8754,991000000002913023133624154685215746276817347878409099625425846266677107527948489039581,0121,1214,0184,0184,1144,2122,4404,5724,6774,7824,8873,1255,0975,2033,4405,4172,5862,6422,6422,7332,8233,0023,0023,0973,1853,2733,2603,0134004134004005005005005000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,431
3,343
4,163
4,021
3,886
3,752
3,616
4,080
5,634
5,494
6,615
6,383
6,204
6,024
6,140
5,988
5,807
5,528
5,801
5,780
5,585
5,312
5,023
1,754
1,970
1,659
1,369
1,183
873
819
777
722
679
638
596
620
1,081
979
906
848
790
733
676
618
561
536
479
421
368
353
337
42
42
42
42
32
32
32
32
5,023
4,916
45,897
45,772
39,137
39,032
38,892
41,119
40,916
40,713
36,682
36,606
36,800
357
595
597
597
1,147
1,148
1,143
1,144
1,144
1,006
1,068
1,136
1,156
1,158
1,159
1,059
20
20
20
43
0
108
139
0
0
0
0
00001391080432020201,0591,1591,1581,1561,1361,0681,0061,1441,1441,1431,1481,14759759759535736,80036,60636,68240,71340,91641,11938,89239,03239,13745,77245,8974,9165,02332323232424242423373533684214795365616186767337908489069791,0816205966386797227778198731,1831,3691,6591,9701,7545,0235,3125,5855,7805,8015,5285,8075,9886,1406,0246,2046,3836,6155,4945,6344,0803,6163,7523,8864,0214,1633,3433,43100000000000000000
> Total Liabilities 
800
800
600
600
900
600
600
500
800
800
600
500
600
664
731
930
986
4,409
1,476
15,180
15,522
15,522
15,431
15,809
16,409
16,409
17,206
17,212
18,998
18,619
17,679
16,537
17,636
17,543
17,315
17,462
17,751
20,320
21,513
20,950
20,950
11,450
20,511
21,272
16,313
18,598
19,135
20,691
8,468
8,784
10,994
12,765
12,651
15,594
16,177
18,304
28,572
25,524
21,604
32,732
29,566
29,580
29,004
25,687
21,391
23,359
33,510
47,522
18,806
15,327
14,750
14,256
15,392
15,971
28,642
30,635
11,766
9,958
16,976
16,476
12,334
11,759
12,672
10,329
11,960
9,578
7,581
5,851
8,668
6,454
5,783
10,331
40,354
48,343
52,250
46,720
44,952
42,626
43,324
44,254
48,647
47,042
46,589
39,275
28,211
23,729
24,633
23,348
37,453
34,605
44,205
44,049
49,176
83,709
60,762
74,819
74,81960,76283,70949,17644,04944,20534,60537,45323,34824,63323,72928,21139,27546,58947,04248,64744,25443,32442,62644,95246,72052,25048,34340,35410,3315,7836,4548,6685,8517,5819,57811,96010,32912,67211,75912,33416,47616,9769,95811,76630,63528,64215,97115,39214,25614,75015,32718,80647,52233,51023,35921,39125,68729,00429,58029,56632,73221,60425,52428,57218,30416,17715,59412,65112,76510,9948,7848,46820,69119,13518,59816,31321,27220,51111,45020,95020,95021,51320,32017,75117,46217,31517,54317,63616,53717,67918,61918,99817,21217,20616,40916,40915,80915,43115,52215,52215,1801,4764,409986930731664600500600800800500600600900600600800800
   > Total Current Liabilities 
600
600
300
400
700
500
400
300
700
700
500
500
500
656
728
930
986
4,409
1,476
1,650
1,992
1,992
1,901
1,784
2,411
2,411
2,961
2,996
4,768
4,592
3,670
2,542
3,613
3,658
3,538
11,758
12,058
14,668
15,900
11,398
11,398
3,814
15,011
15,772
10,813
13,098
13,635
15,191
2,058
2,392
3,589
4,979
4,906
6,474
7,144
7,992
8,634
8,549
8,078
14,483
14,257
14,769
12,872
14,267
12,190
12,905
14,046
8,986
6,629
7,745
7,771
8,010
8,961
10,044
11,172
12,616
2,898
1,240
1,920
1,570
1,477
7,644
8,707
6,515
8,296
6,065
4,219
2,639
5,607
6,454
5,783
10,331
20,354
21,416
25,542
20,238
38,701
36,613
37,556
38,737
41,959
40,839
41,867
26,473
16,623
12,337
13,685
12,600
7,779
7,402
9,440
8,412
13,422
11,889
16,843
18,422
18,42216,84311,88913,4228,4129,4407,4027,77912,60013,68512,33716,62326,47341,86740,83941,95938,73737,55636,61338,70120,23825,54221,41620,35410,3315,7836,4545,6072,6394,2196,0658,2966,5158,7077,6441,4771,5701,9201,2402,89812,61611,17210,0448,9618,0107,7717,7456,6298,98614,04612,90512,19014,26712,87214,76914,25714,4838,0788,5498,6347,9927,1446,4744,9064,9793,5892,3922,05815,19113,63513,09810,81315,77215,0113,81411,39811,39815,90014,66812,05811,7583,5383,6583,6132,5423,6704,5924,7682,9962,9612,4112,4111,7841,9011,9921,9921,6501,4764,409986930728656500500500700700300400500700400300600600
       Short-term Debt 
100
100
0
0
0
0
0
0
0
0
0
0
0
90
73
50
26
6
0
0
0
0
0
105
107
107
285
816
789
541
293
294
338
251
335
8,368
8,417
10,868
10,863
6,838
6,838
106
11,791
12,108
8,833
10,794
10,895
11,406
64
64
339
445
0
0
0
0
0
0
0
5,500
5,500
5,500
2,750
5,500
2,750
2,750
2,750
2,750
0
0
0
0
0
0
0
250
400
-602
-602
-602
-602
4,000
4,000
0
0
0
-602
-602
-3,726
-544
0
0
10,000
1,690
1,693
1,696
1,699
1,702
3,464
3,467
2,043
2,265
3,478
1,723
1,818
1,822
1,798
1,810
1,773
1,789
1,597
3,298
1,996
1,044
5,806
6,558
6,5585,8061,0441,9963,2981,5971,7891,7731,8101,7981,8221,8181,7233,4782,2652,0433,4673,4641,7021,6991,6961,6931,69010,00000-544-3,726-602-6020004,0004,000-602-602-602-60240025000000002,7502,7502,7502,7505,5002,7505,5005,5005,5000000000445339646411,40610,89510,7948,83312,10811,7911066,8386,83810,86310,8688,4178,3683352513382942935417898162851071071050000062650739000000000000100100
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
10,000
10,000
10,000
0
0
1,758
1,758
330
549
1,758
0
0
0
0
0
0
0
0
0
0
0
2,222
4,444
4,4442,222000000000001,7585493301,7581,7580010,00010,00010,00000000000000000004000000000000000000000000000000000000000000000000000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
0
0
0
0
0
0
459
558
721
728
830
890
956
1,158
1,158
615
1,111
1,486
1,486
1,358
1,655
2,469
2,484
1,553
1,209
1,780
1,655
1,194
1,434
2,131
1,800
2,255
2,113
2,113
2,883
1,875
2,034
1,226
1,232
1,350
1,595
1,796
2,077
1,832
2,571
1,970
3,698
3,653
3,692
4,094
3,859
2,988
3,383
2,984
2,892
2,947
1,629
1,713
1,878
2,410
2,347
2,039
2,385
1,305
706
863
1,075
1,340
1,630
1,896
638
1,318
968
875
1,042
2,105
1,913
3,694
1,463
3,617
2,037
2,393
5,910
5,783
10,331
6,122
4,189
7,156
2,714
3,763
1,763
1,979
1,262
4,695
2,476
1,469
1,861
4,325
1,601
1,738
1,748
1,811
2,857
3,477
2,592
1,858
3,362
3,099
2,789
2,7893,0993,3621,8582,5923,4772,8571,8111,7481,7381,6014,3251,8611,4692,4764,6951,2621,9791,7633,7632,7147,1564,1896,12210,3315,7835,9102,3932,0373,6171,4633,6941,9132,1051,0428759681,3186381,8961,6301,3401,0758637061,3052,3852,0392,3472,4101,8781,7131,6292,9472,8922,9843,3832,9883,8594,0943,6923,6533,6981,9702,5711,8322,0771,7961,5951,3501,2321,2262,0341,8752,8832,1132,1132,2551,8002,1311,4341,1941,6551,7801,2091,5532,4842,4691,6551,3581,4861,4861,1116151,1581,1589568908307287215584590000000000000
       Other Current Liabilities 
0
500
300
400
700
500
400
300
0
700
500
500
500
19
9
4
77
2,990
3
36
834
283
756
49
818
310
831
49
311
571
832
51
311
572
832
783
311
572
878
567
567
652
1,172
1,457
581
899
1,217
1,023
130
233
1,276
1,799
2,772
2,515
3,235
3,948
4,193
4,343
4,743
5,253
5,426
6,030
6,828
6,853
7,442
8,038
8,638
3,641
4,343
5,113
5,889
6,727
7,520
8,367
9,230
10,134
602
9,320
15,658
15,508
602
2,000
2,000
4,000
4,000
4,000
602
602
3,214
544
0
0
3,936
15,241
16,397
15,532
32,943
32,852
31,817
33,712
34,925
35,802
36,624
22,593
10,184
8,914
10,149
9,042
4,195
2,756
205
2,522
9,568
7,483
7,938
9,075
9,0757,9387,4839,5682,5222052,7564,1959,04210,1498,91410,18422,59336,62435,80234,92533,71231,81732,85232,94315,53216,39715,2413,936005443,2146026024,0004,0004,0002,0002,00060215,50815,6589,32060210,1349,2308,3677,5206,7275,8895,1134,3433,6418,6388,0387,4426,8536,8286,0305,4265,2534,7434,3434,1933,9483,2352,5152,7721,7991,2762331301,0231,2178995811,4571,1726525675678785723117838325723115183257131149831310818497562838343632,99077491950050050070003004005007004003005000
   > Long-term Liabilities 
0
200
300
200
200
100
200
200
0
100
100
100
100
8
3
0
0
0
0
13,530
0
13,530
13,530
14,025
0
13,998
14,245
14,216
14,230
14,027
14,009
13,995
14,023
13,885
13,777
5,704
5,693
5,652
5,613
9,552
9,552
7,636
5,500
5,500
5,500
5,500
5,500
5,500
6,410
6,392
7,405
7,786
7,745
9,120
9,033
10,312
19,938
16,975
13,526
18,249
15,309
14,811
16,132
11,420
9,201
10,454
19,464
38,536
12,177
7,582
6,979
6,246
6,431
5,927
17,470
18,019
8,868
8,718
15,056
14,906
10,857
4,115
3,965
3,814
3,664
3,513
3,362
3,212
3,061
3,061
0
0
20,000
26,927
26,708
26,482
6,251
6,013
5,768
5,517
6,688
6,203
4,722
12,802
11,588
11,392
10,948
10,748
29,674
27,203
34,765
35,637
35,754
71,820
43,919
56,397
56,39743,91971,82035,75435,63734,76527,20329,67410,74810,94811,39211,58812,8024,7226,2036,6885,5175,7686,0136,25126,48226,70826,92720,000003,0613,0613,2123,3623,5133,6643,8143,9654,11510,85714,90615,0568,7188,86818,01917,4705,9276,4316,2466,9797,58212,17738,53619,46410,4549,20111,42016,13214,81115,30918,24913,52616,97519,93810,3129,0339,1207,7457,7867,4056,3926,4105,5005,5005,5005,5005,5005,5007,6369,5529,5525,6135,6525,6935,70413,77713,88514,02313,99514,00914,02714,23014,21614,24513,998014,02513,53013,530013,53000003810010010010002002001002002003002000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,428
1,209
0
0
0
0
0
0
0
0
0
0
0
0
0
0
000000000000001,2091,4280000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
303
303
303
346
173
185
201
211
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
910
892
1,905
2,286
2,245
3,620
3,533
4,812
14,438
11,475
8,026
18,249
15,309
14,811
13,382
11,420
9,201
10,454
19,464
38,536
12,177
7,582
6,979
6,246
6,431
5,927
17,470
18,019
8,868
8,718
15,056
14,906
10,857
4,115
3,965
3,814
3,664
3,513
3,362
3,212
3,061
0
0
0
20,000
20,000
20,000
20,000
0
0
0
0
0
0
0
8,360
4,028
4,119
4,211
4,264
23,820
0
30,388
31,594
0
0
0
0
000031,59430,388023,8204,2644,2114,1194,0288,360000000020,00020,00020,00020,0000003,0613,2123,3623,5133,6643,8143,9654,11510,85714,90615,0568,7188,86818,01917,4705,9276,4316,2466,9797,58212,17738,53619,46410,4549,20111,42013,38214,81115,30918,2498,02611,47514,4384,8123,5333,6202,2452,2861,9058929100000000000000002112011851733463033033030000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,868
0
0
0
4,266
0
4,266
4,266
3,664
3,664
3,362
3,212
3,061
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000000000000003,0613,2123,3623,6643,6644,2664,26604,2660004,8680000000000000000000000000000000000000000000000000000000000000000000000000000
> Total Stockholder Equity
0
-300
5,900
5,000
4,100
3,300
2,400
1,900
0
600
2,500
2,500
1,800
1,043
404
4,437
3,614
13,820
15,719
16,458
15,004
15,004
12,375
10,644
9,078
9,078
5,676
2,819
489
-1,876
-1,339
-3,508
-5,825
953
-1,515
-3,799
-6,661
-8,559
-12,285
-13,139
-13,139
-4,237
-12,255
-14,199
-9,887
-13,722
-15,501
-17,191
681
-1,432
-4,074
-7,011
-8,394
-11,970
-13,826
-15,599
-26,989
-20,329
-17,979
-30,453
-20,795
-22,704
-23,939
-23,467
-17,606
-20,163
-31,073
-46,288
-17,076
-13,606
-12,353
-13,164
-14,779
-15,493
-28,402
-30,355
4,816
3,159
59,949
73,073
67,721
65,661
61,480
63,485
99,098
95,706
89,078
89,880
170,098
169,199
160,914
150,245
134,045
117,793
107,160
96,052
178,430
132,377
121,054
115,111
102,551
94,390
84,086
79,744
51,375
31,443
20,086
15,413
26,761
18,740
9,345
22,038
14,826
-8,881
73,241
45,773
45,77373,241-8,88114,82622,0389,34518,74026,76115,41320,08631,44351,37579,74484,08694,390102,551115,111121,054132,377178,43096,052107,160117,793134,045150,245160,914169,199170,09889,88089,07895,70699,09863,48561,48065,66167,72173,07359,9493,1594,816-30,355-28,402-15,493-14,779-13,164-12,353-13,606-17,076-46,288-31,073-20,163-17,606-23,467-23,939-22,704-20,795-30,453-17,979-20,329-26,989-15,599-13,826-11,970-8,394-7,011-4,074-1,432681-17,191-15,501-13,722-9,887-14,199-12,255-4,237-13,139-13,139-12,285-8,559-6,661-3,799-1,515953-5,825-3,508-1,339-1,8764892,8195,6769,0789,07810,64412,37515,00415,00416,45815,71913,8203,6144,4374041,0431,8002,5002,50060001,9002,4003,3004,1005,0005,900-3000
   Common Stock
0
1,300
1,300
1,300
1,300
1,300
1,300
1,300
0
1,500
0
0
0
34
34
60
61
115
120
126
132
132
133
133
132
132
132
132
132
132
133
133
134
154
155
155
155
157
157
176
176
176
35
35
35
35
35
36
36
56
56
65
70
113
116
131
132
154
157
159
191
193
194
195
239
241
242
242
247
248
253
255
257
260
265
6
200
200
299
327
328
328
328
338
403
403
403
409
469
472
473
480
479
479
492
511
836
836
848
845
961
990
1,013
1,019
1,472
1,471
1,467
77
177
179
215
247
265
276
417
434
434417276265247215179177771,4671,4711,4721,0191,01399096184584883683651149247947948047347246940940340340333832832832832729920020062652602572552532482472422422412391951941931911591571541321311161137065565636363535353535176176176157157155155155154134133133132132132132132132133133132132126120115616034340001,50001,3001,3001,3001,3001,3001,3001,3000
   Retained Earnings Total Equity00000-721,097-704,4430-694,2100000-601,913-586,706-570,704-554,876-547,639-534,629-486,470-470,039-452,667-428,743-410,188-392,711-376,292-364,592-359,792-351,342-345,999-337,720-332,473-325,471-322,847-316,144-310,600-308,260-302,187-298,074-296,074-283,447-281,238-267,274-266,421000000000000000000000000000000000000000000000000000000000000000000000000
   Accumulated Other Comprehensive Income 
-200
-200
-200
-300
-300
-300
-300
-400
-600
-600
-700
-700
-800
-815
-848
-880
-908
-932
-956
-977
-972
-1,045
-1,045
-1,045
-992
-1,199
-1,362
-1,361
-1,336
-1,430
-1,398
-1,391
-1,325
-1,422
-1,416
-1,391
-1,357
-1,333
-1,273
-1,224
-1,224
-1,045
-1,045
-1,045
-1,045
-1,045
-1,045
-1,045
-1,045
-1,045
-1,045
-1,045
-1,000,000,000,000,000
-877
0
-1,000,000,000,000,000
-1,361
-1,000,000,000,000,000
-1,000,000,000,000,000
-1,000,000,000,000,000
-870
-1,000,000,000,000,000
-1,000,000,000,000,000
-17,750,006,310,000
-834
-1,000,000,000,000,000
-1,000,000,000,000,000
-1,000,000,000,000,000
-891
-1,000,000,000,000,000
-1,000,000,000,000,000
-1,000,000,000,000,000
0
-1,000,000,000,000,000
-1,000,000,000,000,000
-1,000,000,000,000,000
-10
-10
0
0
-31
-31
0
0
-179
-179
0
0
-386
-386
0
0
-1,560
-1,560
0
0
-4,157
386
133
17
-10
3
-1
-9
-27
-30
-34
-44
-129
-65
-95
-99
-66
-184
-134
-84
-84-134-184-66-99-95-65-129-44-34-30-27-9-13-1017133386-4,15700-1,560-1,56000-386-38600-179-17900-31-3100-10-10-1,000,000,000,000,000-1,000,000,000,000,000-1,000,000,000,000,0000-1,000,000,000,000,000-1,000,000,000,000,000-1,000,000,000,000,000-891-1,000,000,000,000,000-1,000,000,000,000,000-1,000,000,000,000,000-834-17,750,006,310,000-1,000,000,000,000,000-1,000,000,000,000,000-870-1,000,000,000,000,000-1,000,000,000,000,000-1,000,000,000,000,000-1,361-1,000,000,000,000,0000-877-1,000,000,000,000,000-1,045-1,045-1,045-1,045-1,045-1,045-1,045-1,045-1,045-1,045-1,045-1,224-1,224-1,273-1,333-1,357-1,391-1,416-1,422-1,325-1,391-1,398-1,430-1,336-1,361-1,362-1,199-992-1,045-1,045-1,045-972-977-956-932-908-880-848-815-800-700-700-600-600-400-300-300-300-300-200-200-200
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
231,049
231,617
0
0
0
0
0
0
0
0
251,389
251,525
252,575
253,090
300,690
301,033
361,837
381,006
377,993
381,477
383,999
388,618
431,168
433,023
434,674
440,813
529,421
533,319
536,733
542,476
543,754
546,057
559,335
565,580
664,064
665,784
667,712
669,125
672,304
680,103
684,987
0
0
0
0
709,590
0
723,069
730,322
0
0
0
0
0
00000730,322723,0690709,5900000684,987680,103672,304669,125667,712665,784664,064565,580559,335546,057543,754542,476536,733533,319529,421440,813434,674433,023431,168388,618383,999381,477377,993381,006361,837301,033300,690253,090252,575251,525251,38900000000231,617231,04900000000000000000000000000000000000000000000000000000000000000
   Treasury Stock0000000000000000000000000000000000000000-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-4-20000000000000000000
   Other Stockholders Equity 
0
3,700
18,000
18,000
18,400
18,400
18,400
19,100
0
20,900
24,800
25,600
25,700
25,724
26,050
30,800
30,914
42,170
45,534
47,598
0
47,725
47,856
47,869
0
47,846
48,618
48,619
48,985
49,125
49,313
49,343
49,593
58,802
58,880
58,999
59,006
59,504
59,504
60,645
60,645
62,797
63,107
63,178
68,795
69,087
69,417
69,683
116,014
126,309
126,427
126,810
-1,000,000,000,000,000
226,536
227,284
-15,599
214,686
-20,329
-17,979
-30,453
231,019
230,789
-23,939
231,613
-1,000,000,000,000,000
-20,163
-31,073
-46,288
242,340
-13,606
-12,353
-13,164
250,195
-15,493
-28,402
-30,355
300,700
301,033
361,837
381,006
378,024
381,477
383,999
388,618
431,347
433,023
434,674
440,813
529,807
533,319
536,733
542,476
545,314
546,057
559,335
565,580
668,221
665,784
667,712
669,125
672,304
680,103
684,987
687,691
705,570
706,433
703,379
709,590
722,049
723,069
730,322
754,823
764,151
772,129
846,654
849,388
849,388846,654772,129764,151754,823730,322723,069722,049709,590703,379706,433705,570687,691684,987680,103672,304669,125667,712665,784668,221565,580559,335546,057545,314542,476536,733533,319529,807440,813434,674433,023431,347388,618383,999381,477378,024381,006361,837301,033300,700-30,355-28,402-15,493250,195-13,164-12,353-13,606242,340-46,288-31,073-20,163-1,000,000,000,000,000231,613-23,939230,789231,019-30,453-17,979-20,329214,686-15,599227,284226,536-1,000,000,000,000,000126,810126,427126,309116,01469,68369,41769,08768,79563,17863,10762,79760,64560,64559,50459,50459,00658,99958,88058,80249,59349,34349,31349,12548,98548,61948,61847,846047,86947,85647,725047,59845,53442,17030,91430,80026,05025,72425,70025,60024,80020,900019,10018,40018,40018,40018,00018,0003,7000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.